177 related articles for article (PubMed ID: 28258895)
1. Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years Later.
Huang SH; Waldron J; Bratman SV; Su J; Kim J; Bayley A; Cho J; Giuliani M; Hope A; Ringash J; Hansen A; de Almeida JR; Goldstein D; Perez-Ordonez B; Weinreb I; Tong L; Xu W; O'Sullivan B
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):159-169. PubMed ID: 28258895
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Clinical Outcomes of Patients with Squamous Cell Carcinoma of the Tonsil Receiving Postoperative Ipsilateral Versus Bilateral Neck Radiotherapy: A Propensity Score Matching Analysis (KROG 11-07).
Kim Y; Cho KH; Moon SH; Lee CG; Keum KC; Lee SW; Ahn YC; Oh D; Kim YS; Won YK; Wu HG; Hah JH; Oh YT
Cancer Res Treat; 2017 Oct; 49(4):1097-1105. PubMed ID: 28183163
[TBL] [Abstract][Full Text] [Related]
3. Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach.
Rusthoven KE; Raben D; Schneider C; Witt R; Sammons S; Raben A
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1365-70. PubMed ID: 19168295
[TBL] [Abstract][Full Text] [Related]
4. Association of Unilateral Radiotherapy With Contralateral Lymph Node Failure Among Patients With Squamous Cell Carcinoma of the Tonsil: A Systematic Review and Meta-analysis.
Razavian NB; D'Agostino RB; Steber CR; Helis CA; Hughes RT
JAMA Netw Open; 2023 Feb; 6(2):e2255209. PubMed ID: 36753275
[TBL] [Abstract][Full Text] [Related]
5. Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil.
Chin RI; Rao YJ; Hwang MY; Spencer CR; Pierro M; DeWees T; Patel P; Sinha P; Gay HA; Daly M; Haughey BH; Nussenbaum B; Adkins DR; Lewis JS; Thorstad WL
Cancer; 2017 Dec; 123(23):4594-4607. PubMed ID: 28881377
[TBL] [Abstract][Full Text] [Related]
6. Risk of post-operative, pre-radiotherapy contralateral neck recurrence in patients treated with surgery followed by adjuvant radiotherapy for human papilloma virus-associated tonsil cancer.
Gershowitz J; Chao HH; Doucette A; Lukens JN; Swisher-McClure S; Weinstein GS; O'Malley BW; Chalian AA; Rassekh CH; Newman JG; Cohen RB; Bauml JM; Aggarwal C; Lin A
Br J Radiol; 2019 Dec; 92(1104):20190466. PubMed ID: 31600090
[TBL] [Abstract][Full Text] [Related]
7. Cancer of the tonsil: the results of ipsilateral radiation treatment.
Jackson SM; Hay JH; Flores AD; Weir L; Wong FL; Schwindt C; Baerg B
Radiother Oncol; 1999 May; 51(2):123-8. PubMed ID: 10435802
[TBL] [Abstract][Full Text] [Related]
8. Ipsilateral radiotherapy for squamous cell carcinoma of the tonsil.
Kennedy WR; Herman MP; Deraniyagala RL; Amdur RJ; Werning JW; Dziegielewski PT; Morris CG; Mendenhall WM
Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):2151-6. PubMed ID: 26223350
[TBL] [Abstract][Full Text] [Related]
9. Unilateral radiotherapy for the treatment of tonsil cancer.
Chronowski GM; Garden AS; Morrison WH; Frank SJ; Schwartz DL; Shah SJ; Beadle BM; Gunn GB; Kupferman ME; Ang KK; Rosenthal DI
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):204-9. PubMed ID: 22019242
[TBL] [Abstract][Full Text] [Related]
10. Ipsilateral neck radiotherapy in N2b well-lateralized tonsil cancer - Approach with caution.
Maskell D; Buckley H; Sission K; Roques T; Geropantas K
Head Neck; 2019 Sep; 41(9):2937-2946. PubMed ID: 31059180
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
[TBL] [Abstract][Full Text] [Related]
12. Risk of contralateral nodal failure following ipsilateral IMRT for node-positive tonsillar cancer.
Gottumukkala S; Pham NL; Sumer B; Myers L; Truelson J; Nedzi L; Khan S; Hughes R; Sher DJ
Oral Oncol; 2017 Dec; 75():35-38. PubMed ID: 29224820
[TBL] [Abstract][Full Text] [Related]
13. Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy.
Mourad WF; Hu KS; Puckett L; Hauerstock D; Shourbaji RA; Li Z; Manolidis S; Schantz S; Tran T; Jacobson A; Urken M; Culliney B; Persky M; Harrison LB
Am J Clin Oncol; 2014 Feb; 37(1):57-62. PubMed ID: 23357967
[TBL] [Abstract][Full Text] [Related]
14. Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: updated results of an institutional clinical management approach.
Dan TD; Raben D; Schneider CJ; Hockstein NG; Witt RL; Dzeda M; Cormier JF; Raben A
Oral Oncol; 2015 Jun; 51(6):616-21. PubMed ID: 25868716
[TBL] [Abstract][Full Text] [Related]
15. Post-operative radiation effects on lymphopenia, neutrophil to lymphocyte ratio, and clinical outcomes in palatine tonsil cancers.
Lin AJ; Rao YJ; Chin RI; Campian J; Mullen D; Thotala D; Daly M; Gay H; Oppelt P; Hallahan D; Adkins D; Thorstad W
Oral Oncol; 2018 Nov; 86():1-7. PubMed ID: 30409288
[TBL] [Abstract][Full Text] [Related]
16. Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma--relation to radiotherapy response and survival.
Friesland S; Mellin H; Munck-Wikland E; Nilsson A; Lindholm J; Dalianis T; Lewensohn R
Anticancer Res; 2001; 21(1B):529-34. PubMed ID: 11299799
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy alone or combined with chemotherapy as definitive treatment for squamous cell carcinoma of the tonsil.
Kennedy WR; Herman MP; Deraniyagala RL; Amdur RJ; Werning JW; Dziegielewski P; Kirwan J; Morris CG; Mendenhall WM
Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):2117-25. PubMed ID: 27059836
[TBL] [Abstract][Full Text] [Related]
18. The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer.
Al-Mamgani A; van Rooij P; Verduijn GM; Mehilal R; Kerrebijn JD; Levendag PC
Laryngoscope; 2013 Feb; 123(2):386-93. PubMed ID: 23404489
[TBL] [Abstract][Full Text] [Related]
19. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W
J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
